Language

Medicine shortages: Belgium · Page 22

Official notices covering supply interruptions, limited availability and resumed supply. Each notice identifies the product, active ingredient, status and reported period.

Data checked:

1530 notices · Page 22 / 31

← Europe overview

National authority sources: Belgium

Recorded notices include resolved cases. The data check date differs from the modification date of an individual authority notice.

Medicine shortages: Belgium · Page 22

Belgium

Clarithromycine Sandoz 250 mg film-coat. tabl. 10

Marketing ended · Commercial reasons
Active ingredient: Clarithromycine

Notice details →
Belgium

Efexor-Exel 150 mg hard caps. prol.-rel. 98

Available again · Not specified
Active ingredient: Venlafaxine

Notice details →
Belgium

Eribulin Baxter 0.44 mg/ml inj. sol. i.v. vial 2 ml

Available again · Not specified
Active ingredient: Eribulin

Notice details →
Belgium

Exacyl 500 mg film-coat. tabl. 20

Nicht verfügbar · Manufacturing delay
Active ingredient: Tranexamic Acid

Notice details →
Belgium

Ezetimibe/Simvastatine Teva 10 mg - 40 mg tabl. 100

Nicht verfügbar · Increased demand
Active ingredient: Simvastatin,Ezetimibe

Notice details →
Belgium

Imitrex SC 6 mg inj. sol. s.c. cartr. 2 x 0.5 ml + 1 x Pen

Nicht verfügbar · Manufacturing delay
Active ingredient: Sumatriptan

Notice details →
Belgium

Intrarosa 6.5 mg pessary 28

Nicht verfügbar · Manufacturing delay
Active ingredient: Prasterone

Notice details →
Belgium

Melatonin AB 2 mg tabl. prol.-rel. 90

Available again · Not specified
Active ingredient: Melatonin

Notice details →
Belgium

Nurofen 400 400 mg coat. tabl. 30

Available again · Not specified
Active ingredient: Ibuprofen

Notice details →
Belgium

Nurofen for Children 100 mg soft chewable caps. 24

Nicht verfügbar · Manufacturing delay
Active ingredient: Ibuprofen

Notice details →
Belgium

Solifenacine/Tamsulosine Teva 6 mg - 0.4 mg tabl. modif.-rel. 90 (90 x 1) UD

Nicht verfügbar · Increased demand
Active ingredient: Tamsulosin ,Solifenacin

Notice details →
Belgium

Tobi Podhaler 28 mg inhal. pwdr. (hard caps.) 224 (4 x 56)

Available again · Not specified
Active ingredient: Tobramycin

Notice details →
Belgium

Tranxene 50 mg film-coat. tabl. 30

Available again · Not specified
Active ingredient: Dipotassium Clorazepate

Notice details →
Belgium

Aceclofenac EG 100 mg film-coat. tabl. 60

Nicht verfügbar · Manufacturing delay
Active ingredient: Aceclofenac

Notice details →
Belgium

Bleomycine Hikma 15 000 IU inj. sol. (pwdr.) i.m./i.perit./i.tumor./i.v./i.pleur./i.arter./s.c. vial 15000 IU

Available again · Not specified
Active ingredient: Bleomycin Sulfate

Notice details →
Belgium

Candesartan Teva 16 mg tabl. 98

Available again · Not specified
Active ingredient: Candesartan Cilexetil

Notice details →
Belgium

Dalacin Vaginal 100 mg/5 g vagin. cream 40 g

Available again · Not specified
Active ingredient: Clindamycin

Notice details →
Belgium

Duracef 250 mg/5 ml or. susp. (pwdr.) 80 ml

Available again · Not specified
Active ingredient: Cefadroxil Monohydrate

Notice details →
Belgium

Duracef 500 mg/5 ml or. susp. (pwdr.) 80 ml

Available again · Not specified
Active ingredient: Cefadroxil Monohydrate

Notice details →
Belgium

Etoposide Accord Healthcare 20 mg/ml inf. sol. (conc.) i.v. vial 5 ml

Available again · Not specified
Active ingredient: Etoposide

Notice details →
Belgium

Felodipine EG Retard 5 mg tabl. prol.-rel. 100

Nicht verfügbar · Manufacturing delay
Active ingredient: Felodipine

Notice details →
Belgium

Gamunex 10 % inf. sol. i.v. vial 100 ml

Available again · Not specified
Active ingredient: Human Normal Immunoglobulin

Notice details →
Belgium

Imatinib Teva 400 mg film-coat. tabl. 30 (30 x 1) UD

Nicht verfügbar · Manufacturing delay
Active ingredient: Imatinib

Notice details →
Belgium

Iomeron 400 mg/ml inj. sol. i.v. vial 100 ml

Available again · Not specified
Active ingredient: Iodine

Notice details →
Belgium

Iomeron 400 mg/ml inj. sol. i.v. vial 200 ml

Available again · Not specified
Active ingredient: Iodine

Notice details →
Belgium

Rozlytrek 100 mg hard caps. 30

Available again · Not specified
Active ingredient: Entrectinib

Notice details →
Belgium

Topiramate EG 100 mg film-coat. tabl. 100

Available again · Not specified
Active ingredient: Topiramate

Notice details →
Belgium

Betahistine Viatris 24 mg tabl. 60

Nicht verfügbar · Sonstige
Active ingredient: Betahistine Dihydrochloride

Notice details →
Belgium

Bisoprolol Viatris 10 mg film-coat. tabl. 100

Nicht verfügbar · Sonstige
Active ingredient: Bisoprolol Fumarate

Notice details →
Belgium

Caelyx Pegylated Liposomal 2 mg/ml inf. sol. (conc.) i.v. vial 25 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Doxorubicin Hydrochloride

Notice details →
Belgium

Coveram 5 mg - 5 mg tabl. 90

Available again · Not specified
Active ingredient: Amlodipine,Perindopril

Notice details →
Belgium

Escitalopram Viatris 20 mg film-coat. tabl. 100

Nicht verfügbar · Sonstige
Active ingredient: Escitalopram

Notice details →
Belgium

Etoricoxib AB 90 mg film-coat. tabl. 7

Available again · Not specified
Active ingredient: Etoricoxib

Notice details →
Belgium

Fingolimod Mylan 0.5 mg hard caps. 28 (28 x 1) UD

Available again · Not specified
Active ingredient: Fingolimod

Notice details →
Belgium

Fluconazole Viatris 200 mg hard caps. 10

Nicht verfügbar · Increased demand
Active ingredient: Fluconazole

Notice details →
Belgium

Gabapentine Sandoz 300 mg hard caps. 200

Nicht verfügbar · Increased demand
Active ingredient: Gabapentin

Notice details →
Belgium

Kali-Sterop 1 g/10 ml inf. sol. (conc.) i.v. amp. 10 x 10 ml

Available again · Not specified
Active ingredient: Potassium Chloride

Notice details →
Belgium

Lercanidipin Sandoz 10 mg film-coat. tabl. 28

Marketing ended · Commercial reasons
Active ingredient: Lercanidipine

Notice details →
Belgium

Metiblo 10 mg/1 ml inj. sol. i.v. amp. 10 x 1 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Methylthioninium Chloride

Notice details →
Belgium

Metiblo 10 mg/1 ml inj. sol. i.v. amp. 100 x 1 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Methylthioninium Chloride

Notice details →
Belgium

Mitoxantrone Sandoz 2 mg/ml inf. sol. (conc.) i.v. vial 5 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Mitoxantrone

Notice details →
Belgium

Nicorette Freshmint 2 mg compr. lozenge 160 (4 x 40)

Available again · Not specified
Active ingredient: Nicotine

Notice details →
Belgium

Olmesartan/Amlodipin/HCT Viatris 40 mg - 5 mg - 12.5 mg film-coat. tabl. 98

Nicht verfügbar · Sonstige
Active ingredient: Olmesartan Medoxomil,Amlodipine,Hydrochlorothiazide

Notice details →
Belgium

Olmetec Plus 20 mg - 12.5 mg film-coat. tabl. 98

Nicht verfügbar · Manufacturing delay
Active ingredient: Olmesartan Medoxomil,Hydrochlorothiazide

Notice details →
Belgium

Olmetec Plus 40 mg - 25 mg film-coat. tabl. 28

Nicht verfügbar · Manufacturing delay
Active ingredient: Hydrochlorothiazide,Olmesartan Medoxomil

Notice details →
Belgium

Pregabalin Sandoz 75 mg hard caps. 14

Marketing ended · Commercial reasons
Active ingredient: Pregabalin

Notice details →
Belgium

Quetiapine AB 150 mg tabl. prol.-rel. 100

Available again · Not specified
Active ingredient: Quetiapine

Notice details →
Belgium

Risperidon Sandoz 2 mg film-coat. tabl. 20

Marketing ended · Commercial reasons
Active ingredient: Risperidone

Notice details →
Belgium

Sevikar 40 mg - 5 mg film-coat. tabl. 28

Nicht verfügbar · Manufacturing delay
Active ingredient: Olmesartan Medoxomil,Amlodipine

Notice details →
Belgium

Solifenacine/Tamsulosine Viatris 6 mg - 0.4 mg tabl. modif.-rel. 200

Nicht verfügbar · Sonstige
Active ingredient: Solifenacin ,Tamsulosin

Notice details →